131 related articles for article (PubMed ID: 37413687)
1. Associations Between Thyroid Eye Disease and Glaucoma Among Those Enrolled in the National Institutes of Health All of Us Research Program: Corrigendum.
Ophthalmic Plast Reconstr Surg; 2023 Jul-Aug 01; 39(4):405. PubMed ID: 37413687
[No Abstract] [Full Text] [Related]
2. Re: "Associations Between Thyroid Eye Disease and Glaucoma Among Those Enrolled in the National Institutes of Health All of Us Research Program".
Sidhu AS; Walker CEL; Al Yassin A; Xiradis N; Tweedie PJ; Kim D; Wong ELS; Lee MK; Tsoi AT; Fu MY; Ouyang MH; Gunasegaram J; Fatima A; Borchert G; Nguyen I; Agar A; Francis IC
Ophthalmic Plast Reconstr Surg; 2024 May-Jun 01; 40(3):356. PubMed ID: 38215458
[No Abstract] [Full Text] [Related]
3. Associations Between Thyroid Eye Disease and Glaucoma Among Those Enrolled in the National Institutes of Health All of Us Research Program.
Delavar A; Radha Saseendrakumar B; Lee TC; Topilow NJ; Ting MA; Liu CY; Korn BS; Weinreb RN; Kikkawa DO; Baxter SL
Ophthalmic Plast Reconstr Surg; 2023 Jul-Aug 01; 39(4):336-340. PubMed ID: 36394556
[TBL] [Abstract][Full Text] [Related]
4. Access to Eye Care Providers and Glaucoma Severity in the National Institutes of Health All of Us Research Program.
Paul M; Kitayama K; Yu F; Tseng VL; Coleman AL
J Glaucoma; 2023 Dec; 32(12):1044-1051. PubMed ID: 38200661
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Depression and Anxiety in a Diverse Population With Thyroid Eye Disease Using the Nationwide NIH All of Us Database: Corrigendum.
Ophthalmic Plast Reconstr Surg; 2023 May-Jun 01; 39(3):305. PubMed ID: 36877172
[No Abstract] [Full Text] [Related]
6. Prevalence of open-angle glaucoma, glaucoma suspect, and ocular hypertension in thyroid-related immune orbitopathy.
Skalicky SE; Borovik AM; Masselos K; Pandya VB; Wang LW; Figueira EC; Wilcsek G; Francis IC
J Glaucoma; 2008; 17(3):249; author reply 249-50. PubMed ID: 18414116
[No Abstract] [Full Text] [Related]
7. [Whether lowering intraocular pressure is needed for thyroid associated ophthalmopathy with intraocular hypertension].
Yang HS; Ye HJ
Zhonghua Yan Ke Za Zhi; 2019 Nov; 55(11):811-813. PubMed ID: 31715677
[TBL] [Abstract][Full Text] [Related]
8. Racial and Ethnic Disparities in Cost-Related Barriers to Medication Adherence Among Patients With Glaucoma Enrolled in the National Institutes of Health All of Us Research Program.
Delavar A; Radha Saseendrakumar B; Weinreb RN; Baxter SL
JAMA Ophthalmol; 2022 Apr; 140(4):354-361. PubMed ID: 35238904
[TBL] [Abstract][Full Text] [Related]
9. [A CONTRIBUTION TO THE DIFFERENTIATION OF THE CLINICAL TYPES OF ENDOCRINE OPHTHALMOPATHY].
DRAEGER J; SCHNEIDER C
Klin Monbl Augenheilkd; 1963 Aug; 143():104-16. PubMed ID: 14083275
[No Abstract] [Full Text] [Related]
10. Aqueous misdirection in thyroid eye disease.
Tripathy D; Rao A; Banerjee A; Padhy D
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25414214
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of intraocular pressure increase and glaucoma prevalence in thyroid eye disease: a mini-review.
Haefliger IO; von Arx G; Pimentel AR
Klin Monbl Augenheilkd; 2010 Apr; 227(4):292-3. PubMed ID: 20408077
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy.
Bradley EA; Sloan JA; Novotny PJ; Garrity JA; Woog JJ; West SK
Ophthalmology; 2006 Aug; 113(8):1450-4. PubMed ID: 16769116
[TBL] [Abstract][Full Text] [Related]
13. Evaluating Discrepancies in Self-Reported Glaucoma and Electronic Health Records in the National Institutes of Health All of Us Database.
Paul ME; Tseng VL; Kitayama K; Yu F; Coleman AL
Ophthalmol Glaucoma; 2023; 6(5):521-529. PubMed ID: 36931428
[TBL] [Abstract][Full Text] [Related]
14. Clinical assessment of patients with thyroid eye disease.
Karra E; Yousseif A; Rose GE; Baldeweg SE
Br J Hosp Med (Lond); 2016 Jan; 77(1):C2-5. PubMed ID: 26903467
[No Abstract] [Full Text] [Related]
15. Prevalence of open-angle glaucoma, glaucoma suspect, and ocular hypertension in thyroid-related immune orbitopathy.
Behrouzi Z; Rabei HM; Azizi F; Daftarian N; Mehrabi Y; Ardeshiri M; Mohammadpour M
J Glaucoma; 2007; 16(4):358-62. PubMed ID: 17570998
[TBL] [Abstract][Full Text] [Related]
16. Graves' quality of life.
Terwee CB; Wiersinga WM
Ophthalmology; 2007 Jul; 114(7):1416-7; author reply 1417-8. PubMed ID: 17613337
[No Abstract] [Full Text] [Related]
17. Latanoprost is effective in reducing high intraocular pressure associated with Graves' ophthalmopathy.
Gumińska M; Kłysik A; Siejka A; Jurowski P
Klin Oczna; 2014; 116(2):89-93. PubMed ID: 25345284
[TBL] [Abstract][Full Text] [Related]
18. Intraocular Pressure and Glaucoma in Thyroid Eye Disease.
Betzler BK; Young SM; Sundar G
Ophthalmic Plast Reconstr Surg; 2022 May-Jun 01; 38(3):219-225. PubMed ID: 34406153
[TBL] [Abstract][Full Text] [Related]
19. Using 24-h intraocular pressure-related patterns to identify open-angle glaucoma in thyroid eye disease.
Ma R; Li X; Peng Z; Guo J; Qian J; Zhang Y
Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):1151-1158. PubMed ID: 36322213
[TBL] [Abstract][Full Text] [Related]
20. Racial, Ethnic, and Socioeconomic Disparities in Glaucoma Onset and Severity in a Diverse Nationwide Cohort in the United States.
Acuff K; Radha Saseendrakumar B; Wu JH; Weinreb RN; Baxter SL
J Glaucoma; 2023 Sep; 32(9):792-799. PubMed ID: 37523618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
